Search

everythinglearnresearchcommunity

for

Search:↓

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Two mouse mutations cause similar hair loss despite different skin changes.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

PCOS is common in young women, especially those aged 21-30, and often involves symptoms like irregular periods, weight gain, and acne.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.